Passively modelocked 50 GHz Er:Yb:glass laser

A diode-pumped Er:Yb:glass miniature laser has been passively mode locked to generate 2.0 ps pulses at a 50 GHz repetition rate with up to 7.5 mW average power. By combining this laser with a dynamic gain equaliser, a flat optical spectrum has been generated with up to 10 discrete channels with a 50 GHz channel spacing locked to the 50 GHz ITU grid.     

Singlemode emission at 2 μm wavelength with InP based quantum dash DFB lasers

Long wavelength distributed feedback (DFB) laser diodes based on InP quantum dash-in-a-well material have been fabricated and investigated at room temperature under continuous-wave operation. Singlemode emission of InP laser diodes at wavelengths above 2 mum is demonstrated for the first time.     

Stretchable and Tunable Microtectonic ZnO‐Based Sensors and Photonics

The concept of realizing electronic applications on elastically stretchable “skins” that conform to irregularly shaped surfaces is revolutionizing fundamental research into mechanics and materials that can enable high performance stretchable devices. The ability to operate electronic devices under various mechanically stressed states can provide a set of unique functionalities that are beyond the capabilities of conventional rigid electronics. Here, a distinctive microtectonic effect enabled oxygen‐deficient, nanopatterned zinc oxide (ZnO) thin films on an elastomeric substrate are introduced to realize large area, stretchable, transparent, and ultraportable sensors. The unique surface structures are exploited to create stretchable gas and ultraviolet light sensors, where the functional oxide itself is stretchable, both of which outperform their rigid counterparts under room temperature conditions. Nanoscale ZnO features are embedded in an elastomeric matrix function as tunable diffraction gratings, capable of sensing displacements with nanometre accuracy. These devices and the microtectonic oxide thin film approach show promise in enabling functional, transparent, and wearable electronics.     

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse

BACKGROUND: The study tested whether level of recovery from major depressive episodes (MDEs) predicts duration of recovery in unipolar major depressive disorder (MDD) patients. METHODS: MDD patients seeking treatment at five academic centers were followed naturalistically for 10 years or longer. Patients were divided on the basis of intake MDE recovery into residual depressive symptoms (SSD; N=82) and asymptomatic (N=155) recovery groups. They were compared on time to first episode relapse/recurrence, antidepressant medication, and comorbid mental disorders. Recovery level was also compared to prior history of recurrent MDEs ( > 4 lifetime episodes) as a predictor of relapse/recurrence. RESULTS: Residual SSD compared to asymptomatic recovery patients relapsed to their next MDE > 3 times faster (median=68 vs. 23 weeks) and to any depressive episode > 5 times faster (median=33 vs. 184 weeks). Residual SSD recovery status was significantly associated with early episode relapse (OR=3.65) and was stronger than history of recurrent MDEs (OR=1.64). Rapid relapse in the SSD group could not be attributed to higher comorbidity or lower antidepressant treatment. LIMITATIONS: Although inter-rater agreement on weekly depressive symptom ratings was very high (ICC > 0.88), some error may exist in assigning recovery levels. Antidepressant treatments were recorded, but were not controlled. CONCLUSIONS: MDE recovery is a powerful predictor of time to episode relapse/recurrence. Residual SSD recovery is associated with very rapid episode relapse which supports the idea that SSD is an active state of illness. Asymptomatic recovery is associated with prolonged delay in episode recurrence. These findings of this present study have important implications for the goals of treatment of MDD and for defining true MDE recovery.     

Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease

We investigated the molecular defect causing high density lipoprotein cholesterol (HDL-C) deficiency in a male proband and his family members. Amplification and sequencing of genomic DNA disclosed a novel base-pair substitution at residue 159 in the apolipoprotein (apo) A-I gene. This substitution resulted in the loss of an AviII restriction site and a predicted substitution of leucine with proline at residue 159. Restriction enzyme analysis demonstrated absence of the AviII site in 19 of 40 biological family members. Compared with familial controls, subjects with the apoA-I(Zavalla) variant had reduced HDL-C (1.16 versus 0.27 mmol/L, P<0.0001), apoA-I (38.7 versus 124.4 mg/dL, P<0.0001), and apoA-II (14.3 versus 19.0 mg/dL, P<0.0001) levels. Two subjects who have developed coronary artery disease to date possess additional cardiovascular risk factors. Other heterozygotes for apoA-I(Zavalla) are presently without symptomatic coronary artery disease. This study identifies a monogenic cause of hypoalphalipoproteinemia, with the single base-pair substitution having a dominant effect on the low HDL-C phenotype. In addition, it extends recent observations that HDL-C deficiency states may be more prone to the development of premature coronary artery disease when accompanied by additional cardiovascular risk factors.     

Conceptual and computational advances in multiple-scattering electronic-structure calculations

A physically transparent transformation of the Korringa-Kohn-Rostoker (KKR or multiple-scattering) method into a tightbinding form is described. The transformation replaces the complicated, slowly decaying, traditional KKR structure constants by exponentially decaying “tight-binding” parameters. The main computational effort consists in the inversion of sparse matrices and scales for surfaces and interfaces, i.e. for systems with two-dimensional periodicity, linearly with the number of layers. This gives the opportunity to treat high-indexed surfaces as an approximation for almost isolated surface steps. Additional adatoms on surfaces and at steps can also be treated and it is discussed that reliable atomic forces and geometric arrangements can be obtained.     

Tunable Pr/sup 3+/-Yb/sup 3+/-doped all-fiber upconversion laser

Fiber lasers in the visible spectral range at 603 and 634 nm were demonstrated using upconversion in fluoride Pr/sup 3+/-Yb/sup 3+/-doped fibers and Bragg gratings photoinduced in germanosilicate fibers. Reliable fine tuning of the all-fiber laser over 6.9 at 603 nm has been demonstrated using high strength fiber Bragg gratings.     

Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: the Fels Longitudinal Study

We used a modification of the isolated perfused rat heart, in which coronary effluent and interstitial transudate were separately collected, to investigate the localization and production of angiotensin II (Ang II) in the heart. During combined renin (0.7 to 1.5 pmol Ang I/mL per minute) and angiotensinogen (6 to 12 pmol/mL) perfusion (4 to 8 mL/min) for 60 minutes (n=3), the steady-state levels of Ang II in interstitial transudate in two consecutive 10-minute periods were 4.3+/-1.5 and 3.6+/-1.5 fmol/mL compared with 1.1+/-0.4 and 1.1+/-0.6 fmol/mL in coronary effluent (mean+/-half range). During perfusion with Ang II (n=5), steady-state Ang II in interstitial transudate was 32+/-19% of arterial Ang II compared with 65+/-16% in coronary effluent (mean+/-SD, P<.02). During perfusion with Ang I (n=5), Ang II in interstitial transudate was 5.1+/-0.6% of arterial Ang I compared with 2.2+/-0.3% in coronary effluent (P<.05). The tissue concentration of Ang II in the combined renin/angiotensinogen perfusions (per gram) was as high as the concentration in interstitial transudate (per milliliter). Addition of losartan (10(-6) mol/L) to the renin/angiotensinogen perfusion (n=3) had no significant effect on the tissue level of Ang II, whereas losartan in the perfusions with Ang I (n=5) or Ang II (n=5) decreased tissue Ang II to undetectably low levels. The results indicate that the heart is capable of producing Ang II and that this can lead to higher levels in tissue than in blood plasma. Cardiac Ang II does not appear to be restricted to the extracellular fluid. This is in part due to AT1-receptor-mediated cellular uptake of extracellular Ang II, but our results also raise the possibility of intracellular Ang II production.     

Fluid-to-fluid scaling for a gravity- and flashing-driven natural circulation loop

In certain natural-circulation reactor systems proposed recently, vapor generation takes place by flashing in an adiabatic riser above the core. A step-by-step facility design procedure was used to define suitable scaling criteria for a refrigerant-113 (R-113) experiment simulating the dynamics and stability of such a loop. The fact that vapor generation does not normally take place in the core allows additional flexibility in designing the model; almost perfect simulation can be achieved, mainly by reducing the height of the facility according to the liquid density ratio and scaling for similar void fraction distributions in the prototype and the model.